Medocity is a leading digital health technology company that has been serving the pharmaceutical and life sciences industry for almost a decade. We provide enterprise-level digital health platform solutions, as well as fit-for purpose applications for Ph 1-4 studies and patient support, to drive study efficiencies and reduce study timelines for biopharmaceutical companies, CROs and sites. Specifically for Clinical Trials and RWE studies, Medocity’s modular and flexible architecture ensures swift configuration and deployment through a fully interoperable and connected digital ecosystem. We have experience and capabilities around the globe in over 90 countries, across any therapeutic area and decentralized, hybrid and virtual clinical trials. Our standard products and services include recruitment, eConsent, ePRO/eCOA/IoT, interactive digital support and digital coaching powered by AI/ML. Medocity’s platform captures valuable real-time clinical insights & real-world data, while engaging patients, sites, and sponsors throughout, while providing early detection and proactive interventions. With omni-channel access in real time from any device (over 400 hundred connected sensors) our technology is interoperable and swift in implementation. It seamlessly integrates with EMR, lab, genetic mapping and APCD data, and other data sources and EDC, CTMS and iRT systems to support site and patient identification. Our latest enhancements include patient genetic and biomarker matching to support swift site identification and patient enrollment. Contact us for more information and for a live demo tailored to your use case and needs. Any Device. Any Disease. Any Where. Contact: Amy Apostoleris, aapostoleris@medocity.com